Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2020.12.21.423796

Identification of Key Genes Potentially Related to Triple Receptor Negative Breast Cancer by Microarray Analysis

Vastrad, B. M.·Vastrad, C. M.·Kotturshetti, I. B.
View original source ↗Export metadata ↓

Abstract

Triple receptor negative breast cancer (TNBC) is the type of gynecological cancer in the elderly women. This study is aimed to explore molecular mechanism of TNBC via bioinformatics analysis. The gene expression profiles of GSE88715 (including 38 TNBC and 38 normal control) was downloaded from the Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) were screened using the limma package in R software. Pathway and gene ontology (GO) enrichment analysis were performed based on various pathway dabases and GO database. Then, InnateDb interactome database, Cytoscape and PEWCC1 were applied to construct the protein-protein interaction (PPI) network and screen hub genes. Similarly, miRNet database, NetworkAnalyst database and Cytoscape were applied to construct the target gene - miRNA network and target gene - TF network, and screen targate genes. Pathway and GO enrichment analysis was further performed for hub genes, gene clusters identified via module analysis and targate genes. The expression of hub genes with prognostic values was validated on the UALCAN, cBio Portal, The Human Protein Atlas, receiver operator characteristic (ROC) curve analysis, RT-PCR analysis and immune infiltration analysis. A total of 949 DEGs were identified in TNBC (469 up regulated genes, and 480 down regulated genes), and they were mainly enriched in the terms of phospholipases, toxoplasmosis, immune response, cell surface, glycolysis, biosynthesis of amino acids, carboxylic acid metabolic process and organic substance catabolic process extracellular space. Hub genes including UBD, HLA-B, MYC and HSP90AB1 were identified via PPI network and modules, which were mainly enriched in immune response, antigen processing and presentation, cell cycle and pathways in cancer. Targate genes including CCDC80, PEG10, HOPX and CCNA2 were identified via target gene - miRNA network and target gene - TF network, which were mainly enriched in extracellular structure organization, validated targets of C-MYC transcriptional activation, ensemble of genes encoding core extracellular matrix including ECM glycoproteins and cell cycle. The top five significantly overexpressed mRNA (ADAM15, BATF, NOTCH3, ITGAX and SDC1) and the top five significantly underexpressed mRNA (RPL4, EEF1G, RPL3, RBMX and ABCC2) were selected for further validation in TNBCpatients and healthy controls. Analysis of the expression of genes in the various databases showed that ADAM15, BATF, NOTCH3, ITGAX, SDC1, RPL4, EEF1G, RPL3, RBMX and ABCC2 expressions have a cancer specific pattern in TNBC. Collectively, ADAM15, BATF, NOTCH3, ITGAX, SDC1, RPL4, EEF1G, RPL3, RBMX and ABCC2 may be useful candidate biomarkers for TNBC diagnosis, prognosis and theraputic targates.

Explore related subjects

bioinformaticsPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Vastrad, B. M., Vastrad, C. M., Kotturshetti, I. B.. 2020-12-22. Identification of Key Genes Potentially Related to Triple Receptor Negative Breast Cancer by Microarray Analysis. https://doi.org/10.1101/2020.12.21.423796

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

deepTools4: Faster, Scalable, and Modernized Genomic Data Analysis

The deepTools suite is widely used for quality control, summarization, and visualization of high-throughput sequencing data. However, as genomic datasets grow in scale and depth, existing tools often become computational bottlenecks. We present deepTools4, a modernized framework designed for high performance, scalability, and enhanced usability, while maintaining seamless integration with the Galaxy platform. Core functionality has been rewritten and thoroughly benchmarked, achieving substantial computational speed-ups. Visualization tools have been modernized to provide more intuitive, high-quality graphical outputs. In addition, our testing framework has been expanded to facilitate continuous development and ensure robustness. We demonstrate the utility of deepTools4 across diverse epigenomics and transcriptomics datasets, highlighting its ability to summarize genome-wide signals, apply a wide range of common normalization methods, and visualize enrichment patterns. The enhanced deepTools4 framework delivers a faster, more scalable solution for reproducible genome-wide analysis and interpretation across many sequencing modalities. Availability: https://github.com/deeptools/deepTools/

bioinformatics↗
bioRxiv2026

Reproducibility and cross-dataset concordance of drug-induced transcriptional responses

Drug-perturbation transcriptomic resources are expanding, but the reproducibility and cross-source consistency of the responses they measure remain critical to their use. We compared six resources using independent replicates, matched-drug analyses, and response decomposition. High agreement in treated expression did not translate into equally repeatable drug-induced changes. Cross-source response concordance was generally limited, including under matched cell and treatment conditions, although some comparisons retained drug-specific information. In Tahoe, a control-expression-only baseline left substantial drug-specific variation unresolved. Measured drug main effects - the average responses across cell lines - provided information for predicting cell-specific interactions, with this relationship retained in a cross-plate validation. Exploratory analyses of structure, target, and external-response representations identified modest signals in selected pipelines. Together, these analyses characterize the reliability and transferability of current perturbation resources and identify prediction of drug main effects as a key bottleneck in the framework examined, motivating shared reference measurements and better recovery of drug-specific responses.

bioinformatics↗
bioRxiv2026

Propensity-Adjusted AUC under Nuisance-Model Misspecification

Propensity adjustment compares medical-image detector scores within groups with similar measured properties, such as stain or focus. We examine its sensitivity to the nuisance model that forms those groups. Under Gaussian latent-index assumptions and exact linear-index strata, a closed-form correlation gives an exact boundary for adjusted AUC to fall below one half. Quadrature matches 36 simulation cells within 0.008. Inflation and attenuation relative to correct adjustment are empirical findings, not general ordering results. An overlap screen and a self-stratified control introduced for this study miss 140 of 141 simulated cells with absolute error above 0.05: checking the fitted propensity cannot certify completeness of the adjustment set. On real pathology corpora, logistic and boosted-tree models using the same 16 features disagree. Among splits where both pass both checks, mean adjusted-AUC gaps are 0.057 on acid-fast bacilli (AFB), 0.048 on Kaggle, and 0.049 on PCam, over three, five, and three splits respectively. These gaps measure model sensitivity; neither estimate is known to be correct. A controlled colour shift moves adjusted AUC relative to model-specific references in the predicted direction in 78 of 80 label-dependent cells. Broader balance and label-fit diagnostics favour trees without certifying their adjusted AUC. We recommend reporting sensitivity across nuisance models alongside these diagnostics. Reversal relative to known truth occurs in constructed stress tests; its frequency in practice remains unknown.

bioinformatics↗